期刊文献+

乳腺癌的分子分型 被引量:19

下载PDF
导出
摘要 乳腺癌是1种严重威胁女性健康的常见恶性肿瘤,近年来罹患此病的患者逐年增多。临床上发现组织学类型和病理分期相同的患者,在临床表现、治疗反应性和预后等方面有相当大的差异,其原因在于乳腺癌存在不同的分子分型。目前分子生物学技术的发展日益迅猛,同时随着人类完整基因图谱的公布,乳腺癌分子分型的研究被越来越多的肿瘤学者关注。
出处 《实用癌症杂志》 2012年第1期98-100,共3页 The Practical Journal of Cancer
  • 相关文献

参考文献31

  • 1Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumors[J].Nature,2000,406(6797):747. 被引量:1
  • 2Sorlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets[J].Proc Natl Acad Sci USA,2003,100(14):8418. 被引量:1
  • 3赵晶,付丽.乳腺癌的分子分型[J].中华乳腺病杂志(电子版),2009,3(2):35-40. 被引量:34
  • 4Badve S,Turbin D,Thorat M A,et al.FOXA1 expression in breast cancer-correlation with luminal subtype A and survival[J].Clin Cancer Res,2007,13(15 Pt 1):4415. 被引量:1
  • 5周波,谢菲,杨德启.乳腺癌分子亚型预测新辅助化疗疗效的研究[J].中国肿瘤临床,2009,36(4):199-202. 被引量:20
  • 6Bocker W,Moll R,Poremba C,et al.Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:a new cell biological concept[J].Lab Invest,2002,82(6):737. 被引量:1
  • 7Boecker W,Buerger H.Evidence of progenitor cells of glandular and myoepithelial cell lineages in the the human adult female breast epithelium:a new progenitor (adult stem) cell concept[J].Cell Prolif,2003,36(Suppl 1):73. 被引量:1
  • 8Stingl J,Eaves C J,Zandieh I,et al.Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue[J].Breast Cancer Res Treat,2001,67(2):93. 被引量:1
  • 9Dontu G,Abdallah W M,Foley J M,et al.In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells[J].Genes Dev,2003,17(10):1253. 被引量:1
  • 10Dontu G,Al Hajj M,Abdallah W M,et al.Stem cells in normal breast development and breast cancer[J].Cell Prolif,2003,36(Suppl 1):59. 被引量:1

二级参考文献55

  • 1杨名添,戎铁华,黄植蕃,曾灿光,龙浩,傅剑华,林鹏,王欣,王思愚,王曦,唐军.可手术乳腺癌6263例临床分析[J].癌症,2005,24(3):327-331. 被引量:46
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 3张清媛,赵文辉,康欣梅.c-erbB1 c-erbB2和丝裂原活化蛋白激酶与乳腺癌三苯氧胺耐药的关系[J].中华肿瘤杂志,2006,28(11):826-830. 被引量:6
  • 4Rouzier R, Perou CM, Symmans -W-F, et al. Breast cancer molecular subtypes respond differendy to preoperative chemotherapy[J]. Clin Cancer Res, 2005, 11(16): 5678-5685. 被引量:1
  • 5Colleoni M, Viale G, Zahrieh D, et al. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment[J].Clin Cancer Res, 2004, 10(19) : 6622-6628. 被引量:1
  • 6Arriola E, Moreno A, Varela M, et al. Predictive value of HER-2 and Topoisomerase Ⅱ lpha in response to primary doxorubicin in breast cancer[J] . EurJ Cancer, 2006, 42(17): 2954-2960. 被引量:1
  • 7Conforti R, Boulet T, Tomasic G, et al. Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials[J]. Ann Oncol, 2007, 18(9): 1477-1483. 被引量:1
  • 8ChangJC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer[J]. Lancet, 2003, 362(9381): 362-369. 被引量:1
  • 9Kaufrnann M, von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations[J].J Clin Oncol, 2003, 21(13): 2600-2608. 被引量:1
  • 10Chollet P, Amat S, Cure H, et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer[J]. BrJ Cancer,2002, 86(7): 1041-1046. 被引量:1

共引文献123

同被引文献190

引证文献19

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部